ABM-1310 Receives FDA Fast Track Designation for BRAF V600E+ Glioblastoma
The FDA has granted fast track designation to ABM-1310 for the treatment of patients with glioblastoma harboring BRAF V600E mutations.
Source: onclive.com
Abm 1310 News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Abm 1310. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Abm 1310 Today - Breaking & Trending Today